Skip to main content
SpringerLink
Log in

Combination of betamethasone and methotrexate for the treatment of scleromyxoedema without paraproteinaemia

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rongioletti F, Merlo G, Cinotti E, et al. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol 2013; 69: 66–72.

    Article  PubMed  Google Scholar 

  2. Bidier M, Zschoche C, Gholam P, et al. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Acta Derm Venereol 2012; 92: 408–9.

    Article  CAS  PubMed  Google Scholar 

  3. Devos T, Thiessen S, Cuyle P, et al. Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years. Ann Hematol 2014; 93: 1927–8.

    Article  CAS  PubMed  Google Scholar 

  4. Bos R, de Waal E, Kuiper H, et al. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema. Rheumatology (Oxford) 2011; 50: 1925–6.

    Article  CAS  Google Scholar 

  5. Shayegi N, Alakel N, Middeke J, et al. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema. Transl Res 2015; 165: 321–4.

    Article  PubMed  Google Scholar 

  6. Horn K, Horn M, Swan J, et al. A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema. J Am Acad Dermatol 2004; 51: S120–3.

    Article  PubMed  Google Scholar 

  7. Kreuter A, Altmeyer P. High-dose dexamethasone in scleromyxedema: report of 2 additional cases. J Am Acad Dermatol 2005; 53: 739–40.

    Article  PubMed  Google Scholar 

  8. El-Darouti M, Hegazy R, Fawzy M, et al. Scleromyxedema: a novel therapeutic approach. J Am Acad Dermatol 2013; 69: 1062–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, 210042, China

    Xiu-Lian Xu, Qiong Wu, Xue-Si Zeng & Jian-Fang Sun

Authors
  1. Xiu-Lian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xue-Si Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian-Fang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xue-Si Zeng or Jian-Fang Sun.

Additional information

Authors contributed equally.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, XL., Wu, Q., Zeng, XS. et al. Combination of betamethasone and methotrexate for the treatment of scleromyxoedema without paraproteinaemia. Eur J Dermatol 26, 391–393 (2016). https://doi.org/10.1684/ejd.2016.2794

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2016.2794

Search

Navigation